NASDAQ:IPSC | Cash Flow Statement | Century Therapeutics, Inc.

Complete source-backed cash-flow history.

Available history
2020-03-31 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30-$34.55M
2026-03-31-$21.65M-$25.26M$584,000.00-$112.62M$126.62M
2025-12-31-$19.17M-$16.08M-$139,000.00$22.36M$53,000.00
2025-09-30-$34.42M
2025-06-30-$32.54M
2025-03-31$76.56M-$34.62M$475,000.00$27.93M$120,000.00
2024-12-31-$36.07M-$24.22M$30.61M-$602,000.00
2024-09-30-$31.23M
2024-06-30-$31.21M
2024-03-31-$28.06M-$30.25M$539,000.00$11.54M$18.2M
2023-12-31-$39.4M-$26.23M$980,000.00$18.6M-$356,000.00
2023-09-30-$32.72M
2023-06-30-$33.29M
2023-03-31-$31.26M-$29.22M$4.99M$31.34M$448,000.00
2022-12-31-$31.68M-$22.91M$6.27M-$4.27M$95,000.00
2022-09-30-$30.75M
2022-06-30-$30.99M
2022-03-31-$37.51M$86.75M$4.07M-$44.04M$26.88M
2021-12-31-$28.19M-$24.35M$16.72M-$20.6M$106,000.00
2021-09-30-$26.01M
2021-06-30-$23.27M
2021-03-31-$18.35M-$22.18M$1.88M-$119.03M$193.49M
2020-12-31-$15.53M-$13.22M$1.9M-$20.78M$38.1M
2020-09-30-$13.07M
2020-06-30-$15.3M
2020-03-31-$9.67M

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31-$9.58M-$103.88M$848,000.00$107.5M$173,000.00
2024-12-31-$126.57M-$110.14M$154,000.00$47.48M$74.56M
2023-12-31-$136.67M-$88.35M$13.74M$61.13M-$9.73M
2022-12-31-$130.93M$14.05M$30.6M-$13.13M$27.16M
2021-12-31-$95.82M-$89M$44.97M-$298.34M$417.77M
2020-12-31-$53.58M-$41.27M$9.83M-$22.76M$47.69M